Mutations in Hh pathway components, such as loss of function mutations of tumor suppressors Ptch and SuFu, or gain of function mutations of Smo or Gli proteins, have been discovered in many cancers [30,31,32,33,34,35,36]. This evidence concerns the gene SMO and cancer.